Abtrace Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Abtrace Ltd. - overview
Established
2018
Location
London, -, UK
Primary Industry
Software
About
Founded in 2018 and based in London, UK, Abtrace Ltd. operates as an AI-based solution for medical expertise. The company was co-founded by CEO Umar Ahmad, COO Helder Soares, and CCO Cristina Correia. In August 2021, Abtrace raised EUR 2.
4 million in Seed funding led by Faber. The company uses machine learning to provide digital solutions that allow healthcare institutions to react and manage the patient’s current diseases and to recognize clinical signs of new conditions. Abtrace has built an AI tool that can plug into the Electronic Health Record (EHR) database and identify which tests or treat patients with a long-term health condition needs or might benefit from. The software allows GPs and healthcare assistants (HCAs) to make informed decisions, automate key elements of disease monitoring, and ensure patients receive consistent, effective care.
The company plans to use its funding from August 2021 to roll the technology out to new GP practices across the UK and expand its engineering and data, science teams.
Current Investors
EIT Health e.V., Faber Ventures, Innovate UK
Primary Industry
Software
Sub Industries
Healthcare IT, Medical Devices & Equipment, Medical Software, Monitoring & Security Software, Storage Management Software
Website
www.abtrace.co
Verticals
Artificial Intelligence, Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Abtrace Ltd. - financials
| Fiscal Year Ended | Aug 31, 2019 | Aug 31, 2020 | Aug 31, 2021 | Aug 31, 2022 |
|---|---|---|---|---|
| Revenue (USD) | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | - | - | - | - |
| Operating Income (USD) | - | - | - | - |
| Operating Margin | - | - | - | - |
| % EBITDA Margin | - | - | - | - |
| NET Income (USD) | (515,922) | - | - | - |
| % Net Margin | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.